Skip Navigation
How Hospitals Detect Controlled Substance Diversion With Behavioral Analytics

Blog Post

How Hospitals Detect Controlled Substance Diversion With Behavioral Analytics

By Adam Rosenberg

Unfortunately, drug diversion happens inside U.S. hospitals every day, with 66% of hospitals surveyed saying their most recent diversion event happened within the past year. Most programs already assume some level of risk exists. What’s less certain is whether controlled substance monitoring software would catch it before the next scheduled audit does.

Many hospitals still lean on periodic chart pulls and unit-based spot checks to answer that question. Those methods catch the transaction flagged that day. They rarely catch the clinician who has been drifting from their own baseline for three months. 

A drug diversion program built on behavioral analytics closes that gap by scoring drift instead of waiting for the next scheduled review.

Why Spot Audits Catch Events and Behavioral Analytics Catches Patterns

A spot audit samples transactions at a single point in time, catching whatever is visible in that snapshot: a missing dose, a late waste entry, a discrepancy between what was ordered and what was documented. That works when diversion looks like a single mistake, not when it looks like a pattern spread across weeks of otherwise normal-looking shifts.

Behavioral analytics scores drift against a clinician’s own baseline rather than a single transaction or even a peer average. A nurse who starts wasting more medication on overnight shifts, or accessing a cabinet more often than their own history shows, generates a signal that an audit sampling a handful of records each month would likely never surface.

The difference comes down to what each method catches and when it runs:

MethodWhat It CatchesTiming
Spot auditA single flagged transactionTied to a review cycle
Behavioral analyticsDrift from a clinician’s own baselineContinuous

The structural issue runs deeper than sampling. Diversion crosses automated dispensing cabinets (ADCs), electronic medication administration records (eMARs), waste logs, and controlled substance vault records. An audit scoped to one of those systems can only ever see part of the picture, which is likely why revised diversion guidelines now call for surveillance technology with advanced analytics capability rather than manual review alone.

None of this is new to healthcare. Physician associations have pushed for evidence-based treatment infrastructure for clinicians struggling with substance use disorder for over a decade. The clinical understanding of the problem has outpaced the operational tools built to catch it in the moment, which is the gap behavioral analytics closes.

How Drug Diversion Monitoring Software Cross-References Dispensing, ADC, and eMAR Data

Behavioral scoring only works if the underlying dataset is complete. Drug diversion monitoring software pulls data from ADCs, eMAR systems, wholesaler records, and vault logs into a single reconciled dataset, rather than leaving each system to be reviewed on its own.

ControlCheck reconciles 95% of transactions automatically, tracing each dispense through its corresponding administration, waste, or return. The remaining discrepancies get flagged for review, with a full audit trail attached to each one.

Gaps in any single source create gaps in the behavioral picture. A system that only pulls ADC data, for example, has no visibility into what actually happened at the bedside. That’s the difference between an alert built on partial data and one built on the full medication lifecycle.

Closed-Loop Reconciliation as the Foundation for Behavioral Scoring

A behavioral baseline needs longitudinal data, not a single snapshot. Closed-loop reconciliation makes that baseline possible, because it ties every transaction to its outcome instead of leaving isolated data points to be interpreted one at a time.

Diversion tends to hide in incomplete reconciliations, in the gaps left when one system’s record doesn’t fully connect to another’s.

What Behavioral Anomalies Signal Nursing and OR Diversion

Once the data is reconciled, the software looks for discrepancies and deviations. Risk scoring weighs waste timing, count corrections, and access frequency against each clinician’s own historical pattern, not a department average. The further any of those drift from that baseline, the more weight the flag carries.

Nursing and operating room settings carry the most weight in that scoring, and the variance share by setting shows why:

SettingShare of Flagged Variances
Nursing67%
Procedural/OR30%
Pharmacy3%

Variance data by setting shows nursing and OR activity accounts for the overwhelming majority of flagged transactions, largely because both settings draw from electronic medical records and automated dispensing cabinets rather than the more centralized data pharmacy settings generate.

High-risk drugs get weighted differently, too. Fentanyl has been historically tied to roughly a quarter of all flagged variances, which keeps it prioritized in scoring models even when the surrounding transaction volume looks unremarkable. For a drug diversion program built around unit-level review, that weighting means investigators spend limited time on transactions most likely to pose real risk, rather than chasing documentation noise.

How Controlled Substance Monitoring Software Scores Risk by Employee and Unit

Individual scoring and unit-level scoring solve different problems, and a mature drug diversion program needs both running at once.

At the individual level, ControlCheck’s Individual Risk Identification Score (IRIS) assigns a continuously updated risk score to each employee, using machine learning and peer benchmarking to rank behavioral severity over alert volume. This is what controlled substance monitoring software is built to do at the individual level. More alerts isn’t a better program if most of them are documentation noise rather than real risk.

At the unit level, scoring surfaces systemic gaps an individual score alone would miss, like a shift pattern or a specific cabinet location that consistently produces higher-risk transactions regardless of which employee is on duty.

The payoff shows up in how investigations perform once they open. Data-flagged cases are three times more likely to result in confirmed diversion than cases opened through routine review, because the flag itself is based on a pattern rather than a hunch.

Continuous, standing scoring also changes behavior on its own. Staff working under ongoing surveillance don’t get a predictable audit window to work around, which is a meaningfully different deterrent than a review that happens on a schedule.

What a Defensible Investigation Workflow Includes From First Flag to Closure

A flag is the start of an investigation, not the end of one, and a drug diversion program’s credibility depends on what happens between those two points. A defensible workflow includes four elements:

  • A standardized checklist tied to the type of flag, not an ad hoc review built case by case
  • A centralized, collaborative workflow for notes, attachments, and linked transactions, so evidence lives in one place rather than scattered across emails
  • Direct participation from a multidisciplinary diversion committee, since pharmacy, nursing, compliance, and legal each see different parts of the same case
  • A documented resolution for every case, whether that resolution confirms diversion or closes it as a documentation issue

The investment shows up in the timeline. Software-initiated investigations now close in 63 days on average, down from 91 days two years earlier, largely because evidence collection no longer depends on manually assembling records from separate systems.

Why the Audit Trail Matters Beyond the Case Itself

A complete audit trail supports more than the case in front of you. It’s also what a DEA or state board review asks for first, and incomplete documentation remains the leading cause of flagged variances in the first place.

Roughly half of all flagged variances trace back to incorrect documentation rather than confirmed diversion, which means the same audit trail that closes a case efficiently also reduces how many cases need to be opened at all.

See How Your Program Compares

A drug diversion program that scores behavior continuously closes the gap a periodic audit leaves open, since prevention and detection stop being separate initiatives once monitoring runs constantly instead of on a review cycle.

Compare your hospital’s variance rate, investigation timeline, and staffing model against nationwide benchmarks in Bluesight’s diversion trends report, then request a ControlCheck demo to see how continuous behavioral scoring would work inside your own program.